We recently published a list of 10 Worst Booming Stocks to Buy According to Short Sellers. In this article, we are going to ...

As retail investors flock to Viking Therapeutics, the biotech firm is also catching the eye of billionaire fund managers like ...

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...

Three Motley Fool contributors think they've identified dirt-cheap healthcare stocks to buy right now. Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP), Gilead Sciences (NASDAQ: GILD), and ...

Dr Vivienne Cox believes that carbohydrates and sweet treats were fuelling her body and keeping amyotrophic lateral sclerosis ...

An office and lab property in Thousand Oaks has sold in an all-cash transaction. Los Angeles-based Alta West Partners and an ...

Warren Buffett's strategy of investing in companies with strong moats can be applied to REITs for building a solid investment ...

Australia’s La Trobe University and the Bangalore Bioinnovation Centre (BBC) based in the Indian state of Karnataka will establish a Bio Innovation Corridor paving the way for the sharing of skills, ...

With the local market share of its existing brands ranging from 25 percent to 100 percent, BFBIO has a strong portfolio of ...

The core premise of Measure 110 was that “a health-based approach to addiction and overdose is more effective, humane and cost-effective than criminal punishments.” That decriminalization not only ...

Another biotech startup revealed plans Friday evening for an initial public offering, making it the sixth startup to list new ...